Clinical Trial Update: Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating DOTAREM for MRI imaging of central nervous system lesions; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Diseases

Drugs mentioned

• DOTAREM (Gadoterate meglumine)

Snippet

Sponsor: Guerbet | Conditions: Diagnostic Self Evaluation, Central Nervous System Diseases | Phase 3 | Status: COMPLETED | Results posted: 2014-05-29